about
The role of oxidative stress in Parkinson's diseaseParkinson's disease as a result of agingGenetic variability of respiratory complex abundance, organization and activity in mouse brainMitochondrial Polymorphisms Significantly Reduce the Risk of Parkinson DiseaseMitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutantsMice with mitochondrial complex I deficiency develop a fatal encephalomyopathy.Caenorhabditis elegans: a model to investigate oxidative stress and metal dyshomeostasis in Parkinson's diseaseAcetyl L-carnitine protects motor neurons and Rohon-Beard sensory neurons against ketamine-induced neurotoxicity in zebrafish embryos.The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson's disease in Italians.Monomer DJ-1 and its N-terminal sequence are necessary for mitochondrial localization of DJ-1 mutants.Rasagiline: an anti-Parkinson drug with neuroprotective activity.Oxidative stress in neurodegenerative diseases: therapeutic implications for superoxide dismutase mimetics.A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein.Modifications of the iron-neuromelanin system in Parkinson's disease.Expanding insights of mitochondrial dysfunction in Parkinson's disease.Genetic findings in Parkinson's disease and translation into treatment: a leading role for mitochondria?Methionine sulfoxide reductase A protects dopaminergic cells from Parkinson's disease-related insultsAMPA receptor-dependent H2O2 generation in striatal medium spiny neurons but not dopamine axons: one source of a retrograde signal that can inhibit dopamine releaseNeuroprotective function of DJ-1 in Parkinson's disease.Generic cell dysfunction in neurodegenerative disorders: role of surfaces in early protein misfolding, aggregation, and aggregate cytotoxicity.Protein folding and aggregation into amyloid: the interference by natural phenolic compoundsOpposing effects of ketamine and acetyl L-carnitine on the serotonergic system of zebrafish.Proteomic analysis of rat brain mitochondria following exposure to dopamine quinone: implications for Parkinson disease.Biomarkers for Alzheimer disease in cerebrospinal fluid, urine, and blood.Mitochondrial dynamics in Parkinson's disease.Proteomic identification of dopamine-conjugated proteins from isolated rat brain mitochondria and SH-SY5Y cells.Emerging roles of mitochondrial membrane dynamics in health and disease.Mitochondrial proteomics as a selective tool for unraveling Parkinson's disease pathogenesis.To live or to die: a matter of processing damaged DNA termini in neurons.New insights on Parkinson's disease genes: the link between mitochondria impairment and neuroinflammation.Protective effects of zonisamide against rotenone-induced neurotoxicity.Protective effects of decursin and decursinol angelate against amyloid β-protein-induced oxidative stress in the PC12 cell line: the role of Nrf2 and antioxidant enzymes.Assessment of the direct and indirect effects of MPP+ and dopamine on the human proteasome: implications for Parkinson's disease aetiology.Proper SUMO-1 conjugation is essential to DJ-1 to exert its full activities.The Neuroprotective Effect of Dimethyl Fumarate in an MPTP-Mouse Model of Parkinson's Disease: Involvement of Reactive Oxygen Species/Nuclear Factor-κB/Nuclear Transcription Factor Related to NF-E2.Reactive oxygen species generation by the ethylene-bis-dithiocarbamate (EBDC) fungicide mancozeb and its contribution to neuronal toxicity in mesencephalic cells.Direct evidence for S-nitrosation of mitochondrial complex I.Bioenergetic regulation of microglia.Astragaloside IV attenuates the H2O2-induced apoptosis of neuronal cells by inhibiting α-synuclein expression via the p38 MAPK pathway.
P2860
Q24307946-1B589CC5-8EBA-45C5-AB36-120F532C4C68Q28084395-1542E005-4E0E-49E5-92E0-FAFC85A14E57Q28397261-DA245E41-0DA0-40F1-8B50-34334B7A89E8Q29398392-4A5F7D8B-80D2-457F-8177-CC48397237EAQ29615627-FA0B1765-C142-4FBB-BB38-0C46DF101379Q30484862-ED0F6CA6-DC8B-4043-88E9-32F50A0ED06AQ33658107-DA2AEAB9-36C0-4D38-BA8A-169A62CC49F0Q33787815-E4682ED5-31BB-41E3-8209-7BDD7EBA28ADQ33978288-C577A43E-25ED-47BA-ACEE-A0307C18EC45Q34411109-2B017555-A16D-488F-B47D-99B955E299DAQ34552123-EBAA10BC-AE0A-4C11-ABE0-27E82A39F647Q35006961-AA9C29FD-FF26-4A7A-8466-F0085D5AD04DQ35116171-BF96A74A-5E69-4DCB-B0E2-F38C76E18513Q36109452-C69363D0-2609-433A-BD18-9DEFC8858146Q36370608-650DC389-6AE2-406C-A4EE-C3F22BED44FDQ36404133-D9D29C97-2EE0-4FD4-A47E-6E7C892EED59Q36499640-5F623DBE-08FA-4C04-BD58-38383A2DD9D4Q36841249-8515844C-6785-4F8A-A286-43845289AA9CQ36893230-C86354A1-A8BA-4EA3-9FC2-4F2E7BDC0269Q36899553-F3B01B6D-5233-4DF3-978D-D482EA50BD68Q36954090-5089E773-6E95-4712-8747-D9E1734D5B22Q37007345-E385C7C7-0651-4A08-9C00-E55538BC838AQ37114029-0B7F4D9C-2D38-4AF1-8D22-9C6F3F2508C5Q37269603-71BEC734-A248-490F-99B9-7E622B407C7DQ37273675-449E7384-B1CD-4FBC-8392-0AEE58A15FBFQ37364337-C68E6A28-7217-4975-959E-5F80BC7347BCQ37381903-A9A02FEE-7674-43DD-A51C-E822D99BA3C3Q37488246-0B4DECBF-5413-4935-9938-3D56E00AA4F9Q37727186-C0EE27C9-2FF4-4A5C-BB24-BBBD58EE6154Q37830005-4D9E8B26-B03E-48CD-B93D-DCDFD36AEA03Q38430373-9C3BD0E7-728A-4CD2-9171-21D7901C48F7Q39076196-CA17F7F4-9067-427D-9EA5-8C274787A977Q39578575-28207611-37D9-4BA2-9402-8D6172F042A8Q40049783-935771FF-0E6D-4E19-B5D7-F4642EF4E970Q40405262-1546EEAA-03C7-450B-9464-709D848B3C8FQ41467663-AB748A49-9087-41F8-ABE4-733ABA218EF0Q42840855-C6E3F266-D28C-46FC-BD4B-878891881C54Q43226776-E844AD44-FF05-40B4-969E-94F14676E134Q46004195-DD04885D-EFDE-4FFF-9864-A5968FCD5B5FQ46283192-66EC099A-9BCD-425C-82E3-5E0AC1EF1D87
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Mitochondrial involvement in Parkinson's disease.
@ast
Mitochondrial involvement in Parkinson's disease.
@en
Mitochondrial involvement in Parkinson's disease.
@nl
type
label
Mitochondrial involvement in Parkinson's disease.
@ast
Mitochondrial involvement in Parkinson's disease.
@en
Mitochondrial involvement in Parkinson's disease.
@nl
prefLabel
Mitochondrial involvement in Parkinson's disease.
@ast
Mitochondrial involvement in Parkinson's disease.
@en
Mitochondrial involvement in Parkinson's disease.
@nl
P1476
Mitochondrial involvement in Parkinson's disease.
@en
P2093
P304
P356
10.1016/S0197-0186(01)00124-3
P577
2002-05-01T00:00:00Z